Danimer Scientific CEO Stephen Croskrey to Take Part in White House-Hosted Summit on Biotechnology and Biomanufacturing
September 14 2022 - 8:45AM
Business Wire
Croskrey will join a panel on biomanufacturing
for the bioeconomy
Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the
“Company”) chief executive officer Stephen Croskrey will be taking
part in a high-level Summit on Biotechnology & Biomanufacturing
for the American Bioeconomy, being hosted today by the White House
Administration.
The summit, which will be livestreamed here, celebrates the
vision, innovation and dedication across the United States to
developing bio-based solutions to global challenges facing the
country, and is being held in conjunction with President Biden’s
Sept. 12, 2022, executive order launching a National Biotechnology
and Biomanufacturing Initiative to ensure that products invented in
the United States can be manufactured here as well. The president
also recently signed the landmark CHIPS & Science Act, which
makes historic investments to strengthen American manufacturing,
research and development, science and technology.
At the summit, Croskrey will take part in a panel on
biomanufacturing for the bioeconomy. The summit will also include a
high-level roundtable with members of Congress, cabinet
secretaries, and other industry and academic leaders, as well as a
panel on biotechnology research and development to solve pressing
challenges.
“I’m honored to be included in this summit on behalf of Danimer
Scientific and the bioplastics industry,” Croskrey said. “Since our
company’s founding in 2004, Danimer has been laser-focused on
finding environmentally friendly, economically feasible solutions
to the ever-growing plastic waste crisis. I look forward to working
with the White House Administration to advance President Biden’s
executive order and to continue developing and producing
biodegradable products to reduce humans’ impact on our
environment.”
Biotechnology utilizes microbes to make specialty chemicals and
compounds in a process called biomanufacturing, which is
increasingly being embraced as an alternative to
petrochemical-based production to make plastics, fuels, materials
and medicines. According to industry analysis, bioengineering could
account for more than a third of global output of manufacturing
industries before the end of the decade — almost $30 trillion in
value.
For more information, please visit
www.DanimerScientific.com.
About Danimer Scientific
Danimer is a pioneer in creating more sustainable, more natural
ways to make plastic products. For more than a decade, its
renewable and sustainable biopolymers have helped create plastic
products that are biodegradable and compostable and return to
nature instead of polluting our lands and waters. Danimer’s
technology can be found in a vast array of plastic end products
that people use every day. Applications for its biopolymers include
additives, aqueous coatings, fibers, filaments, films and
injection-molded articles, among others. Danimer holds more than
430 granted patents and pending patent applications in more than 20
countries for a range of manufacturing processes and biopolymer
formulations. For more information, visit
www.DanimerScientific.com.
Forward‐Looking Statements
Please note that in this press release we may use words such as
“appears,” “anticipates,” “believes,” “plans,” “expects,”
“intends,” “future,” and similar expressions which constitute
forward-looking statements within the meaning of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are made based on our expectations and
beliefs concerning future events impacting the Company and
therefore involve a number of risks and uncertainties. We caution
that forward-looking statements are not guarantees and that actual
results could differ materially from those expressed or implied in
the forward-looking statements. Potential risks and uncertainties
that could cause the actual results of operations or financial
condition of the Company to differ materially from those expressed
or implied by forward-looking statements in this release include,
but are not limited to, the overall level of consumer demand on our
products; general economic conditions and other factors affecting
consumer confidence, preferences, and behavior; disruption and
volatility in the global currency, capital, and credit markets; the
financial strength of the Company's customers; the Company's
ability to implement its business strategy, including, but not
limited to, its ability to expand its production facilities and
plants to meet customer demand for its products and the timing
thereof; risks relating to the uncertainty of the projected
financial information with respect to the Company; the ability of
the Company to execute and integrate acquisitions; changes in
governmental regulation, legislation or public opinion relating to
our products; the Company’s exposure to product liability or
product warranty claims and other loss contingencies; disruptions
and other impacts to the Company’s business, as a result of the
COVID-19 global pandemic and government actions and restrictive
measures implemented in response; stability of the Company’s
manufacturing facilities and suppliers, as well as consumer demand
for our products, in light of disease epidemics and health-related
concerns such as the COVID-19 global pandemic; the impact on our
business, operations and financial results from the ongoing
conflict in Ukraine; the impact that global climate change trends
may have on the Company and its suppliers and customers; the
Company's ability to protect patents, trademarks and other
intellectual property rights; any breaches of, or interruptions in,
our information systems; the ability of our information technology
systems or information security systems to operate effectively,
including as a result of security breaches, viruses, hackers,
malware, natural disasters, vendor business interruptions or other
causes; our ability to properly maintain, protect, repair or
upgrade our information technology systems or information security
systems, or problems with our transitioning to upgraded or
replacement systems; the impact of adverse publicity about the
Company and/or its brands, including without limitation, through
social media or in connection with brand damaging events and/or
public perception; fluctuations in the price, availability and
quality of raw materials and contracted products as well as foreign
currency fluctuations; our ability to utilize potential net
operating loss carryforwards; and changes in tax laws and
liabilities, tariffs, legal, regulatory, political and economic
risks. More information on potential factors that could affect the
Company's financial results is included from time to time in the
Company's public reports filed with the Securities and Exchange
Commission, including the Company's Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.
All forward-looking statements included in this press release are
based upon information available to the Company as of the date of
this press release, and speak only as of the date hereof. We assume
no obligation to update any forward-looking statements to reflect
events or circumstances after the date of this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220914005345/en/
For Danimer: Investors ir@danimer.com Phone: 229-220-1103
Media Anthony Priwer apriwer@daltonagency.com Phone:
615-515-4891
Danimer Scientific (NYSE:DNMR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Danimer Scientific (NYSE:DNMR)
Historical Stock Chart
From Apr 2023 to Apr 2024